Kang JD, Georgescu HI, McIntyre-Larkin L, Stefanovic-Racic M, Evans CH. Herniated cervical intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine (Philos Pa 1976). 1995;20:2373–8.
Kang JD, Georgescu HI, McIntyre-Larkin L, Stefanovic-Racic M, Donaldson WF, Evans CH. Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine (Philos Pa 1976). 1996;21:271–7.
Evans C. Potential biologic therapies for the intervertebral disc. J Bone Jt Surg Am. 2006;88:95–98.
Phillips KL, Jordan-Mahy N, Nicklin MJ, Le Maitre CL. Interleukin-1 receptor antagonist deficient mice provide insights into pathogenesis of human intervertebral disc degeneration. Ann Rheum Dis. 2013;72:1860–7.
Article CAS PubMed Google Scholar
Le Maitre CL, Hoyland JA, Freemont AJ. Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an in situ zymographic and gene therapy study. Arthritis Res Ther. 2007;9:R83.
Article PubMed PubMed Central Google Scholar
Le Maitre CL, Freemont AJ, Hoyland JA. The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther. 2005;7:R732–45.
Article PubMed PubMed Central Google Scholar
Phillips KL, Cullen K, Chiverton N, Michael AL, Cole AA, Breakwell LM, et al. Potential roles of cytokines and chemokines in human intervertebral disc degeneration: interleukin-1 is a master regulator of catabolic processes. Osteoarthr Cartil. 2015;23:1165–77.
Binshtok AM, Wang H, Zimmermann K, Amaya F, Vardeh D, Shi L, et al. Nociceptors are interleukin-1beta sensors. J Neurosci. 2008;28:14062–73.
Article CAS PubMed PubMed Central Google Scholar
Nishida K, Kang JD, Gilbertson LG, Moon SH, Suh JK, Vogt MT, et al. Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. Spine (Philos Pa 1976). 1999;24:2419–25.
Nishida K, Kang JD, Suh JK, Robbins PD, Evans CH, Gilbertson LG. Adenovirus-mediated gene transfer to nucleus pulposus cells. Implications for the treatment of intervertebral disc degeneration. Spine (Philos Pa 1976). 1998;23:2437–42.
Nishida K, Gilbertson LG, Moon S, Evans CH, Robbins PD, Kang JD. Transgene expression one year after in-vivo adenovirus-mediated gene transfer to the intervertebral discs of an immuno-competent animal. Orthopaedic Trans. 2000;25: abstract 341.
LeMaitre CL, Freemont AJ, Hoyland JA. A preliminary in vitro study into the use of IL-1Ra gene therapy for the inhibition of intervertebral disc degeneration. Int J Exp Pathol. 2005;87:17–28.
Brewster RC, Weinert FM, Garcia HG, Song D, Rydenfelt M, Phillips R. The transcription factor titration effect dictates level of gene expression. Cell. 2014;156:1312–23.
Article CAS PubMed PubMed Central Google Scholar
Wallach CJ, Kim JS, Sobajima S, Lattermann C, Oxner WM, McFadden K, et al. Safety assessment of intradiscal gene transfer: a pilot study. Spine J. 2006;6:107–12.
Levicoff EA, Kim JS, Sobajima S, Wallach CJ, Larson JW 3rd, Robbins PD, et al. Safety assessment of intradiscal gene therapy II: effect of dosing and vector choice. Spine (Philos Pa 1976). 2008;33:1509–16.
Hordeaux J, Buza EL, Dyer C, Goode T, Mitchell TW, Richman L, et al. Adeno-associated virus-induced dorsal root ganglion pathology. Hum Gene Ther. 2020;31:808–18.
Article CAS PubMed Google Scholar
Leckie SK, Bechara BP, Hartman RA, Sowa GA, Woods BI, Coelho JP, et al. Injection of AAV2-BMP2 and AAV2-TIMP1 into the nucleus pulposus slows the course of intervertebral disc degeneration in an in vivo rabbit model. Spine J. 2012;12:7–20.
留言 (0)